Literature DB >> 8050177

Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis.

G Vitale1, C Mocciaro, R Malta, G Gambino, A Spinelli, C Giordano, G Stassi, F Arcoleo, S Milano, E Cillari.   

Abstract

The levels of soluble CD4 (sCD4), sCD8 and beta 2-microglobulin (beta 2-M) were measured in sera from patients with visceral leishmaniasis during the course of infection. Levels of sCD4, sCD8 and beta 2-M were raised significantly above levels in normal sera and returned to the normal range after recovery. The decrease in the levels of sCD8 was related to a reduction of anaemia, leukopenia and thrombocytopenia. In contrast, sCD4 levels fluctuated during the period of infection. beta 2-M returned within normal range more rapidly than sCD8 secretion. Our results suggest that T cells are activated during infection, and that it is also possible that the raised levels of these soluble molecules play a role in the impairment of protective immunity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050177      PMCID: PMC1534687          DOI: 10.1111/j.1365-2249.1994.tb06081.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Soluble CD8 during T cell activation.

Authors:  B E Tomkinson; M C Brown; S H Ip; S Carrabis; J L Sullivan
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

Review 2.  Cross-linking of CD4 and CD8 with the T-cell receptor complex: quaternary complex formation and T-cell repertoire selection.

Authors:  F Emmrich
Journal:  Immunol Today       Date:  1988-10

3.  Activators of protein kinase C induce dissociation of CD4, but not CD8, from p56lck.

Authors:  T R Hurley; K Luo; B M Sefton
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

4.  Visceral leishmaniasis in Kenyan children.

Authors:  G M Anabwani; A D Bryceson
Journal:  Indian Pediatr       Date:  1982-10       Impact factor: 1.411

5.  Circulating factor from a kala-azar patient suppresses in vitro antileishmanial T cell proliferation.

Authors:  D J Wyler
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

6.  Counterimmunoelectrophoresis (CIEP) and ELISA tests in the diagnosis of canine leishmaniasis.

Authors:  S Mansueto; M D Miceli; P Quartararo
Journal:  Ann Trop Med Parasitol       Date:  1982-04

7.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

8.  Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.

Authors:  M M Reddy; M Lange; M H Grieco
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

9.  Immunosuppression in Kenyan visceral leishmaniasis.

Authors:  M Ho; D K Koech; D W Iha; A D Bryceson
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

10.  The dynamics of granuloma formation in experimental visceral leishmaniasis.

Authors:  M J McElrath; H W Murray; Z A Cohn
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.

Authors:  S Mansueto; G Vitale; C Mocciaro; G Gambino; P Colletti; P Mansueto; A Spinelli; M Affronti; N Chifari; F Arcoleo; S Milano; E Cillari
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.